ORDERS $150+ QUALIFY FOR FREE SHIPPING

Menu
Tesamorelin 5mg research peptide by Peptico – COA-documented, third-party tested, verified purity
Tesamorelin 5mg peptide from Peptico – research-grade, batch-tested, documented certificate of analysis
Tesamorelin 5mg research-grade peptide – Peptico lab-verified, COA-documented, purity-tested
Tesamorelin 10mg research peptide by Peptico – COA-documented, third-party tested, verified purity
Tesamorelin 10mg peptide from Peptico – research-grade, batch-tested, documented certificate of analysis
Tesamorelin 10mg research-grade peptide – Peptico lab-verified, COA-documented, purity-tested

Tesamorelin

Tesamorelin is a synthetic growth hormone-releasing hormone (GHRH) analog composed of a stabilized amino acid sequence designed to interact with GHRH receptor pathways. It is commonly utilized in research settings to study metabolic signaling, lipid metabolism pathways, and endocrine system dynamics. Supplied by Peptico for research-use only.

- +

All Orders Ship within
24 Business Hours

Free Shipment Protection

Priority Shipment Options Available at Checkout

Format
Lyophilized powder
Approved Exclusively For
Laboratory and Analytical Research
Handling
Utilize appropriate sterile technique and controlled environments during preparation.
Short-Term Storage - Lyophilized Powder Form Only
  • For maximum potency, lyophilized materials may generally be stored between 2°C and 8°C (36°F to 46°F) for up to 4 weeks when maintained in their original, sealed lyophilized form.
  • Maintain a cool and dry environment.
  • Protect from moisture and light.
  • Minimize exposure to humidity and temperature fluctuations.
Long-Term Storage - Lyophilized Powder Form Only
  • For maximum potency and long-term preservation, lyophilized materials may generally be stored between -20°C and -80°C (-4°F to -112°F) for up to 1 year when preserved in their original, sealed lyophilized form.
  • Maintain a cool and dry environment.
  • Protect from moisture and light.
  • Minimize exposure to humidity and temperature fluctuations.

Important Note:

Storage guidelines apply only to lyophilized material in its original, sealed, and untampered vial.

COA History

All shipped products include a unique batch number printed on the vial label. This batch number corresponds to a third-party Certificate of Analysis tested by an ISO/IEC 17025 accredited laboratory.


The COA attached at the top of this page, along with the COA marked “Current” below, represents the active production batch currently being shipped. This same batch number will appear on the label of your vial.


For previous purchases, please refer to COAs marked “Historical” and match the batch number on your vial to the batch number listed on the corresponding COA.


For a complete record of testing documentation across all products and batches, please visit our COA Vault, which includes both current and historical COAs.

Loading COA history...

Frequently Researched Together:

CJC-1295 + Ipamorelin 10mg research blend by Peptico – COA-documented, third-party tested, verified purity

CJC-1295 + Ipamorelin

$57.50

View More
TB-500 10mg research peptide by Peptico – COA-documented, third-party tested, verified purity

TB-500

$49.50

View More
Retatrutide 10mg research peptide by Peptico – COA-documented, third-party tested, verified purity

Retatrutide

From $67.50

View More
GHK-CU 50mg research peptide by Peptico – COA-documented, third-party tested, verified purity

GHK-CU

From $27.50

View More
BPC-157 5mg research peptide by Peptico – COA-documented, third-party tested, verified purity

BPC-157

From $27.50

View More

Molecular Profile

What is Tesamorelin?

Scientific compound data sourced from PubChem.

Chemical Structure Chemical structure depiction for Tesamorelin PubChem CID 16137828
Type
Chemical compound
PubChem CID
16137828
CAS Number
218949-48-5
Molecular Formula
C221H366N72O67S
Molecular Weight
5136.00 g/mol
IUPAC Name
(4S)-4-[[2-[[(2S)-5-amino-2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-5-amino-2-[[2-[[(2S)-2-[[(2S)-2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-4-amino-2-[[(2S,3R)-2-[[(2S)-2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-3-carboxy-2-[[(2S)-2-[[(2S)-2-[[(E)-hex-3-enoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]propanoyl]amino]propanoyl]amino]propanoyl]amino]-3-methylpentanoyl]amino]-3-phenylpropanoyl]amino]-3-hydroxybutanoyl]amino]-4-oxobutanoyl]amino]-3-hydroxypropanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-5-carbamimidamidopentanoyl]amino]hexanoyl]amino]-3-methylbutanoyl]amino]-4-methylpentanoyl]amino]acetyl]amino]-5-oxopentanoyl]amino]-4-methylpentanoyl]amino]-3-hydroxypropanoyl]amino]propanoyl]amino]-5-carbamimidamidopentanoyl]amino]hexanoyl]amino]-4-methylpentanoyl]amino]-4-methylpentanoyl]amino]-5-oxopentanoyl]amino]-3-carboxypropanoyl]amino]-3-methylpentanoyl]amino]-4-methylsulfanylbutanoyl]amino]-3-hydroxypropanoyl]amino]-5-carbamimidamidopentanoyl]amino]-5-oxopentanoyl]amino]-5-oxopentanoyl]amino]acetyl]amino]-5-[[(2S)-1-[[(2S)-4-amino-1-[[(2S)-5-amino-1-[[(2S)-1-[[(2S)-1-[[2-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-amino-4-methyl-1-oxopentan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-1-oxopropan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-1-oxopropan-2-yl]amino]-2-oxoethyl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-4-carboxy-1-oxobutan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-1,4-dioxobutan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-5-oxopentanoic acid
InChIKey
QBEPNUQJQWDYKU-BMGKTWPMSA-N
View Tesamorelin PubChem record

Research

Sources & References

API results related to Tesamorelin.

PubChem Compound data

Tesamorelin compound record

CID: 16137828

(4S)-4-[[2-[[(2S)-5-amino-2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-5-amino-2-[[2-[[(2S)-2-[[(2S)-2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-4-amino-2-[[(2S,3R)-2-[[(2S)-2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-3-carboxy-2-[[(2S)-2-[[(2S)-2-[[(E)-hex-3-enoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]propanoyl]amino]propanoyl]amino]propanoyl]amino]-3-methylpentanoyl]amino]-3-phenylpropanoyl]amino]-3-hydroxybutanoyl]amino]-4-oxobutanoyl]amino]-3-hydroxypropanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-5-carbamimidamidopentanoyl]amino]hexanoyl]amino]-3-methylbutanoyl]amino]-4-methylpentanoyl]amino]acetyl]amino]-5-oxopentanoyl]amino]-4-methylpentanoyl]amino]-3-hydroxypropanoyl]amino]propanoyl]amino]-5-carbamimidamidopentanoyl]amino]hexanoyl]amino]-4-methylpentanoyl]amino]-4-methylpentanoyl]amino]-5-oxopentanoyl]amino]-3-carboxypropanoyl]amino]-3-methylpentanoyl]amino]-4-methylsulfanylbutanoyl]amino]-3-hydroxypropanoyl]amino]-5-carbamimidamidopentanoyl]amino]-5-oxopentanoyl]amino]-5-oxopentanoyl]amino]acetyl]amino]-5-[[(2S)-1-[[(2S)-4-amino-1-[[(2S)-5-amino-1-[[(2S)-1-[[(2S)-1-[[2-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-amino-4-methyl-1-oxopentan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-1-oxopropan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-1-oxopropan-2-yl]amino]-2-oxoethyl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-4-carboxy-1-oxobutan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-1,4-dioxobutan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-5-oxopentanoic acid

Formula: C221H366N72O67S • Molecular weight: 5136

View source
PubMed Scientific paper

Injectable Peptides in Sports Medicine: A Structured Narrative Review of Evidence, Safety, and Antidoping Implications.

JBJS reviews

Villegas Meza AD, Nocek M, Mitchell BC et al. • 2026

Publication date: 2026 May 1

View source
PubMed Scientific paper

Differing Presentations of Excess Visceral Abdominal Fat in People Living With HIV: Two Clinical Cases Highlighting Distinct Therapeutic Pathways With Tesamorelin and Glucagon-Like Peptide-1 Receptor Agonists.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Beach R, Tims-Cook Z, McGary CS et al. • 2026

Publication date: 2026 May 15

View source
PubMed Scientific paper

Therapeutic Peptides in Aesthetic, Metabolic and Endocrine Conditions: Effects, Safety, Clinical Applications, and Future Perspectives.

International journal of molecular sciences

Renke G, Chinellato L • 2026

Publication date: 2026 Apr 27

View source
PubMed Scientific paper

Combined antiretroviral therapy with low- or normal-protein, high-calorie diets appears to induce significant deleterious electrocardiographic changes in a rodent model.

Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas

Chege BM, Mwangi PW, Githinji CG et al. • 2026

Publication date: 2026

View source
PubMed Scientific paper

Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance.

Sports medicine (Auckland, N.Z.)

Mendias CL, Awan TM • 2026

Publication date: 2026 Apr 12

View source

⚠️ IMPORTANT RESEARCH NOTICE

This product is NOT for human consumption.
 Supplied strictly for laboratory and analytical research use only, it is not intended to diagnose, treat, cure, or prevent any disease, and must not be used for clinical, veterinary, or therapeutic applications.
All information provided, including referenced research and data, is for educational and scientific context only and should NOT be interpreted as medical guidance.
By purchasing, you confirm that you are a qualified individual or entity operating in accordance with applicable local, state, and federal regulations. All responsibility for handling, use, and compliance rests solely with the purchaser.

Scroll to Top